Population
Pregnant patients, including those with premature labor
Design
Review
Authors
Loading...
Supports cautious use and fetal surveillance with prostaglandin synthetase inhibitors in pregnancy; leaves open prospective validation of proposed guidelines.
This review provides therapeutic guidelines and surveillance recommendations for the use of prostaglandin synthetase inhibitors in pregnancy due to their potential for serious fetal side effects.
Veyver et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: